Metagenomics Sequencing Market by Product and Service (Reagents and Consumables, Instruments, Services, Analysis and Data Interpretation Solutions); Workflow (Sample Processing and Library Preparation, Sequencing, Data Processing and Analysis); Technology (16s rRNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics); Application (Drug Discovery, Ecological and Environmental Applications, Clinical Diagnostics, Soil Microbiome Applications, Industrial Applications, Veterinary Applications, Other Applications) and Geography: Global Market Size Estimates and Forecast (2022–2030)
The market crossed the US$ 1.0 billion mark in 2022 and is expected to hit US$ 4.5 billion by 2030, recording a CAGR of 18.0% during the forecast period.
The metagenomics sequencing market has been significantly growing with an increase in demand for drug discovery, clinical diagnostics, and the growing prevalence of genetic disorders. Further, the increase in advancements regarding DNA sequencing and the rise in the extension of metagenomics sequencing applications boost the growth of the global metagenomics sequencing market. In addition, developing countries also offer lucrative opportunities for metagenomics sequencing product manufacturers. The sample processing and library preparation hold the maximum share in the market attributed mainly to the growing number of metagenome sequencing research projects being conducted, the availability of technologically advanced and robust sample processing and library preparation assay kits, and the demand for efficient library preparation products.
Within the report, the market is segmented into product and service, workflow, technology, application, and geography. By product and service, the market is further segmented into reagents and consumables, instruments, services, and analysis and data interpretation solutions. On the basis of workflow, the market is segmented into sample processing and library preparation, sequencing, and data processing and analysis. By technology, the market is categorized into 16s rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de-novo assembly, and metatranscriptomics. Based on application, the market is divided into drug discovery, ecological and environmental applications, clinical diagnostics, soil microbiome applications, industrial applications, veterinary applications, and other applications. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Continuous Technological Advancement in NGS Platform will Boost Market Growth
Metagenomic is a research field involving genomic analysis of microbial DNA from environmental communities. Metagenomic sequencing techniques enable researchers to analyze genes in the given sample. The method also allows for the assessment of microbial diversity and identifying the presence of microbes in various environments. Various steps are involved in metagenomics sequencing, including DNA extraction, library preparation, sequencing, assembly, annotation, and statistical analysis.
The rapid technological advancements in sequencers have enabled the advent of an efficient, portable, and easy-to-use NGS platform, which can provide a fast and accurate result. The introduction of such advanced technologies provides a competitive edge to the market players; as a result, several companies are increasingly adopting strategic alliances to maintain a strong position in the market.
Rising adoption during COVID-19 is one of the major factors accelerating market growth.
Recent advancements in sequencing have allowed the genomes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), to be sequenced within hours or days of a case being identified. The novel metagenomic sequencing is critical to the detection and description of the novel pathogen. Early sharing of SARS-CoV-2 genome sequences allowed molecular diagnostic assays to be designed rapidly, enhancing global preparedness.
Recent strategic developments in the metagenomics sequencing market
The metagenomics sequencing market has undergone several significant developments, and a few of these have been mentioned below:
- In December 2021, Oriel Research launched a metagenomics pipeline for supporting the metagenomics analysis to allow full synergism between big data bioinformatics analytical tools and novel biological platforms, to deliver metagenomics discoveries to patients
- In April 2019, Pacific Biosciences of California, Inc. (US) launched the Sequel II System. The new product reduces project costs and timelines by approximately eight times the data output compared to the previous Sequel System.
Several players drive the metagenomics sequencing market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. BGI Genomics Co., Ltd., Eurofins Genomics, Illumina, Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd, Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc., and Thermo Fisher Scientific Inc. is among the prominent players operating in the market.
Target audience for the report:
- Drug developing companies
- Contract development and manufacturing organization,
- Clinical diagnostics -related associations, organizations, forums, and alliances
- Government bodies, such as regulating authorities and policymakers
- Venture capitalists, private equity firms, and start-up companies
- Drug distributors and sales firms
- End users of drug discovery
- Research institutes, organizations, and consulting companies
Scope of the report:
In this report, the market has been segmented on the basis of:
- Product and Service:
- Reagents and consumables
- Instruments
- Services
- Analysis and data interpretation solutions
- Workflow:
- Sample processing and library preparation
- Sequencing
- Data processing and analysis
- Technology:
- 16s rRNA sequencing
- Shotgun metagenomic sequencing
- Whole-genome sequencing and de-novo assembly
- Metatranscriptomics
- Application:
- Drug discovery
- Ecological and environmental applications
- Clinical diagnostics
- Soil microbiome applications
- Industry applications
- Veterinary applications
- Other applications
- Region
- North America
- Europe
- Asia Pacific (APAC)
- South & Central America
- Middle East & Africa
- Companies profiled
- Illuminia, Inc.
- Thermo Fisher Scientific, Inc.
- PerkinElmer
- Eurofins Scientific
- Novogene Corporation
- Oxford Nanopore Technologies Ltd.
- BGI Genomics Co.
- Macrogen Inc.
- Pacific Biosciences of California, Inc.
- Swift Biosciences Inc.
- Illuminia, Inc.
- Thermo Fisher Scientific, Inc.
- PerkinElmer
- Eurofins Scientific
- Novogene Corporation
- Oxford Nanopore Technologies Ltd.
- BGI Genomics Co.
- Macrogen Inc.
- Pacific Biosciences of California, Inc.
- Swift Biosciences Inc.